SC 13D

Company

Sarepta Therapeutics, Inc.

Filed

May 5, 2015

Accession Number

0001562371-15-000003

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →